Oncology
Imatinib (Imatib 100/400)
Imatinib
Imatinib oral solid — targeted therapy for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). WHO-GMP certified, export-ready.
Composition
Imatinib
Packaging
As per manufacturer specification
Manufacturer
Mehadia Tradelinks
$0.89per tablet
In Stock — Ships within 24hrs
Worldwide shipping
CoA included
Quantity:
1
💡 Bulk pricing available — Contact us for orders of 100+ units for additional discounts. All orders include Certificate of Analysis and export documentation.
Imatinib (Imatib 100/400) contains Imatinib, a targeted therapy agent. This product works as a tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity. It is primarily indicated for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Manufactured by Mehadia Tradelinks in compliance with WHO-GMP standards, each batch undergoes rigorous quality testing including HPLC assay, dissolution testing, and stability studies. Available for pharmaceutical export with Certificate of Analysis and full regulatory documentation.
